くえん酸カリウム·水和物

Potassium Citrate

HCID 2735208

基本情報

CAS
6100-05-6
標準SMILES
O.O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[K+].[K+].[K+]
InChIKey
PJAHUDTUZRZBKM-UHFFFAOYSA-K
分子式
C6H7K3O8
平均分子量
324.41 g/mol
単同位体質量
323.9052116

名称と識別子

優先名称
Potassium Citrate
IUPAC
tripotassium;2-hydroxypropane-1,2,3-tricarboxylate;hydrate
現地名
くえん酸カリウム·水和物
英語名
Potassium citrate monohydrate
分子式
C6H11KO8
分子量
250.24

名称と別名

Potassium citrate monohydrateKalii citrasUROCIT-KK-cit-vEE90ONI6FFINS NO.332(II)INS-332(II)E-332(II)NSC-760107CHEBI:64746EffercitrateCymaclear
名称をさらに表示
くえん酸カリウム水和物くえん酸カリウム·水和物くえん酸トリカリウム·水和物くえん酸カリウム,第三くえん酸三カリウム一水和物くえん酸三カリウム,1水和物くえん酸三カリウム(1水和物)くえん酸カリウム三塩基性一水和物クエン酸カリウム 三塩基性 一水和物くえん酸三カリウム一水和物, 99+%くえん酸トリカリウム・水和物くえん酸カリウム・水和物tri-Potassium citrate monohydrateクエン酸カリウムTRIPOTASSIUM CITRATE MONOHYDRATEHydroxycitric acid (tripotassium hydrate)Potassium citrate hydrateCITRIC ACID TRIPOTASSIUM SALT MONOHYDRATEKH2PO49tri-Potassium citrateTrikaliumcitratH2O,BPPotassium Citrate FCC
Potassium-citKali CitricumPot citPot cit effUrocit-k 5meqCitrate, PotassiumRefChem:6154DTXSID0041222

データベース識別子

CAS
6100-05-6、866-84-2
PubChem CID
2735208
DTXSID
DTXSID8042501
ChEMBL
CHEMBL3989822
ChEBI
CHEBI:64746
UNII
EE90ONI6FF
EC Number
612-062-1、934-739-3

物性

構造計算による物性

極性表面積
142 Ų
水素結合供与体数
2
水素結合受容体数
8
回転可能結合数
2
重原子数
17

実験および物理化学的性質

Density1.98 @25 °C
Physical DescriptionWhite odorless solid; [Merck Index] White powder or granules; [Alfa Aesar MSDS]

物理化学的性質

融点
275 °C · 275 °C (dec.)(lit.)
比重(密度)
1.98 · 1.98
貯蔵温度
Inert atmosphere,Room Temperature
溶解性
2 O: · H2O: 1M at20℃、透明、無色
外見
粒状
比重
1.98 · 1.98

化学的性質

化学的特性White/clear crystalline powder

安全と法規制

GHS分類

GHS Classification · 4 件

This chemical does not meet GHS hazard criteria for 100% (181 of 181) of all reports.

Not Classified;Reported as not meeting GHS hazard criteria by 181 of 181 companies. For more detailed information, please visit ECHA C&L website.

Aggregated GHS information provided per 181 reports by companies from 2 notifications to the ECHA C&L Inventory.;Reported as not meeting GHS hazard criteria per 181 of 181 reports by companies.;There are 0 notifications provided by 0 of 181 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Not Classified;Reported as not meeting GHS hazard criteria by 1 of 1 companies. For more detailed information, please visit ECHA C&L website.

危険有害性情報

Regulatory Information · 2 件

Chemical: 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, tripotassium salt, monohydrate

Tripotassium citrate monohydrate: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, tripotassium salt, monohydrate: Human health tier I assessment
Hazards SummaryMay cause irritation; [Alfa Aesar MSDS] See Tripotassium citrate.
EPA Safer ChemicalChemical: Potassium citrate, monohydrate; Green circle - The chemical has been verified to be of low concern based on experimental and modeled data.
Hazard Classes and Categories · 2 件

Not Classified

Not Classified

安全と保護具

Protective Action Criteria (PAC) · 6 件

2.1 [mg/m3]

23 [mg/m3]

140 [mg/m3]

2.2 [mg/m3]

24 [mg/m3]

150 [mg/m3]

毒性情報

Toxicity SummarySafe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org

法規制情報

Regulatory Information · 2 件

Chemical: 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, tripotassium salt, monohydrate

Tripotassium citrate monohydrate: Does not have an individual approval but may be used under an appropriate group standard

安全データ

F
3
wgk
1
tsca
Yes
hs_code
29181500
risk_code
22-35
hazard_code
F,T,C,Xi

化学と産業

薬理情報

ATC Code · 2 件

A - Alimentary tract and metabolism;A12 - Mineral supplements;A12B - Potassium;A12BA - Potassium;A12BA02 - Potassium citrate

QA - Alimentary tract and metabolism;QA12 - Mineral supplements;QA12B - Potassium;QA12BA - Potassium;QA12BA02 - Potassium citrate

Pharmacodynamics · 1 件

Potassium citrate induces changes in the urine which renders urine less susceptible to the formation of crystals and stones from salts e.g. calcium oxalate, calcium phosphate and uric acid. Increased citrate levels in the urine will make complexation with calcium which decrease the calcium ion activity and decrease the chance for the formation of calcium phosphate crystals. Citrate also inhibits the spontaneous nucleation of calcium oxalate and calcium phosphate.

Mechanism of Action · 1 件

After oral administration of potassium citrate, its metabolism yields alkaline load. Potassium Citrate therapy appears to increase urinary citrate mainly by modifying the renal handling of citrate, rather than by increasing the filtered load of citrate. In addition to raising urinary pH and citrate, Potassium Citrate increases urinary potassium by approximately the amount contained in the medication. In some patients, Potassium Citrate causes a transient reduction in urinary calcium.

Metabolism/MetabolitesPotassium Citrate is absorbed and the citrate is metabolised to bicarbonate.
FDA Pharmacological Classification · 4 件

KALI CITRICUM

Calcium Chelating Activity [MoA]; Decreased Coagulation Factor Activity [PE]; Calculi Dissolution Agent [EPC]; Acidifying Activity [MoA]; Anti-coagulant [EPC]

POTASSIUM CITRATE

Calculi Dissolution Agent [EPC]; Calcium Chelating Activity [MoA]; Decreased Coagulation Factor Activity [PE]; Acidifying Activity [MoA]; Anti-coagulant [EPC]

MeSH Pharmacological Classification · 2 件

Agents that promote the excretion of urine through their effects on kidney function.

Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here.

用途と製造

Uses · 2 件

CIR ingredient: Potassium Citrate

Used in food (sequestrant, emulsifier, and stabilizer) and in medicine as an alkalinizing agent and antiurolithic; [Merck Index] Used as a flavoring agent, nutritional supplement, pH control agent, and sequestrant for foods; [FDA]

Household Products · 2 件

Information on 2 consumer products that contain Potassium Citrate in the following categories is provided:;• Commercial / Institutional

Information on 29 consumer products that contain Potassium Citrate in the following categories is provided:;• Auto Products;• Commercial / Institutional;• Inside the Home

Use Classification · 4 件

EPA Safer Chemical Functional Use Classes -> Chelating Agents;Processing Aids and Additives

Safer Chemical Classes -> Green circle - The chemical has been verified to be of low concern

Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients

Food Additives -> ACIDITY_REGULATOR; SEQUESTRANT; STABILIZER -> JECFA Functional Classes

応用分野 · 5 件

用途重金属分析における補助キレート剤、緩衝剤。

用途緩衝剤、pH調整剤、調製液原料。

用途医薬品原料

使用Tripotassium Citrate Monohydrate is used in manufacturing method of printed circuit board for autonomous vehicle to perform recognition, judgment, determination and execution.Citric acid is a weak organic acid that is known as a commodity chemical, as more than a million tonnes are produced every year by mycological fermentation on an industrial scale using crude sugar solutions, such as molasses and strains of Aspergillus niger. Citric acid is widely distributed in plants and in animal tissues and fluids and exist in greater than grace amounts in variety of fruits and vegetables, most notably in citrus fruits such as lemon and limes. Citric acid is mainly used as an acidifier, flavoring agent and chelating agent. Citric acid is also a metabolite of Dimethyl Fumarate (D464965), a compound

一般的な説明Potassium citrate tribasic monohydrate (KCTM) is a potassium salt that has been reported to be efficient in forming aqueous two-phase system (ATPS) with UCON 50-HB-5100, a random copolymer. This product is a high quality pharmacopoeia product that meets the testing specifications of USP (United States Pharmacopoeia). It can be employed in research and pilot studies.

調製方法 · 2 件

Potassium citrate is prepared by adding either potassium bicarbonate or potassium carbonate to a solution of citric acid until effervescence ceases. The resulting solution is then filtered and evaporated to dryness to obtain potassium citrate.

純化方法It solubility in H2O is 154% and it loses H2O at 180o. [Beilstein 3 III 1091.]

上流・下流製品情報

サプライヤー100 社

国药集团化学试剂有限公司86-21-63210123 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
Shandong chuangyingchemical Co., Ltd.18853181302 · [email protected]
上海康朗生物科技有限公司021-61998208 18217752821 · [email protected]
天津市光复科技发展有限公司022-85689490 13132141716 · [email protected]

補足説明

定義ChEBI: A hydrate that is the monohydrate form of potassium citrate.

関連反応

3 件

化合物ノート

読み込み中…